Hyperbaric Oxygen, Neutrophil-oxidative Burst, and Cytokines
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Lindell K Weaver, MD
Intermountain Health Care, Inc.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Intermountain Medical Center
Murray, Utah, United States
Lindell K. Weaver, MDRecruiting - Intermountain Healthcare, Lds Hospital
Salt Lake City, Utah, United States
Lindell K Weaver, MDSusan Churchill, APRN-NPRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2015
- Primary completion
- 31 Dec 2023
- Completion
- 31 Dec 2023
- Last update posted
- 4 Aug 2022
- Registered enrollment
- 40
- Registry id
- NCT02563678
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.